TREVI THERAPEUTICS INC (TRVI) Top Institutional Shareholders

TREVI THERAPEUTICS INC (TRVI) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended March 31, 2026. The institutional investors covered on this page collectively reported approximately $1.61B in TRVI holdings during the latest filing period.

Nea Management Company, Llc is currently the largest disclosed institutional shareholder of TRVI tracked by InsiderSet, reporting ownership valued at approximately $157.74M in its March 31, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $216.45M, representing an estimated gain of +37.22% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 50% of the total disclosed TRVI value among the investors covered in this analysis. Major shareholders include Nea Management Company, Llc, Blackrock, Inc., Frazier Life Sciences Management, L.P., and several other long-term asset managers with concentrated positions in TREVI THERAPEUTICS INC (TRVI).

This page ranks the largest institutional TRVI shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

195

Total Reported Value

$1.61B

Largest Holder

Nea Management Company, Llc

Largest Position

$157.74M

Insider Transactions (90d)

0

Latest Filing Quarter

Q1 2026

New Institutional Positions

173

Funds Exiting Positions

0

Page 1 of 4
NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Nea Management Company, Llc8.97%13,222,228$157,741,180$216,447,872+$58,706,692+37.22%
Blackrock, Inc.0.00%10,240,186$122,165,419$167,631,845+$45,466,426+37.22%
Frazier Life Sciences Management, L.P.3.05%9,939,547$118,578,796$162,710,384+$44,131,588+37.22%
Fmr Llc0.01%8,038,061$95,894,063$131,583,059+$35,688,996+37.22%
Wellington Management Group Llp0.01%5,189,088$61,905,820$84,945,371+$23,039,551+37.22%
Vivo Capital, Llc5.07%5,094,668$60,779,389$83,399,715+$22,620,326+37.22%
Vanguard Capital Management Llc0.00%4,978,567$59,394,304$81,499,142+$22,104,838+37.22%
Marshall Wace, Llp0.05%3,966,019$47,314,607$64,923,731+$17,609,124+37.22%
Rubric Capital Management Lp0.54%3,712,373$44,288,610$60,771,546+$16,482,936+37.22%
Mpm Bioimpact Llc3.04%3,298,430$39,350,270$53,995,299+$14,645,029+37.22%
Viking Global InvestorsOle Andreas Halvorsen0.11%3,198,644$38,159,823$52,361,802+$14,201,979+37.22%
Alliancebernstein L.P.0.01%2,845,472$35,625,309$46,580,377+$10,955,068+30.75%
Geode Capital Management, Llc0.00%2,778,231$33,150,121$45,479,641+$12,329,520+37.19%
State Street Corp0.00%2,665,313$31,797,184$43,631,174+$11,833,990+37.22%
Eventide Asset Management, Llc0.52%2,622,306$31,284,111$42,927,149+$11,643,038+37.22%
Orbimed Advisors Llc0.64%2,454,400$29,280,992$40,178,528+$10,897,536+37.22%
Logos Global Management Lp1.47%2,400,000$28,632,000$39,288,000+$10,656,000+37.22%
Vestal Point Capital, Lp0.72%2,166,504$25,846,393$35,465,670+$9,619,277+37.22%
Acorn Capital Advisors, Llc7.27%2,144,844$25,587,989$35,111,096+$9,523,107+37.22%
Artia Global Partners Lp5.42%2,013,602$24,022,272$32,962,665+$8,940,393+37.22%
Affinity Asset Advisors, Llc1.40%2,000,172$23,862,052$32,742,816+$8,880,764+37.22%
Frontier Capital Management Co Llc0.24%1,994,292$23,791,904$32,646,560+$8,854,656+37.22%
Emerald Advisers, Llc0.69%1,839,566$21,946,022$30,113,695+$8,167,673+37.22%
Siren, L.L.C.0.59%1,786,867$21,317,323$29,251,013+$7,933,690+37.22%
Pictet Asset Management Holding Sa0.02%1,706,048$20,353,153$27,928,006+$7,574,853+37.22%
Raymond James Financial Inc0.01%1,687,977$20,137,565$27,632,183+$7,494,618+37.22%
Soleus Capital Management, L.P.0.78%1,620,000$19,326,600$26,519,400+$7,192,800+37.22%
Pivotal Bioventure Partners Investment Advisor Llc6.63%1,553,726$18,535,951$25,434,495+$6,898,544+37.22%
Octagon Capital Advisors Lp1.96%1,485,000$17,716,050$24,309,450+$6,593,400+37.22%
Emerald Mutual Fund Advisers Trust0.73%1,262,492$15,061,530$20,666,994+$5,605,464+37.22%
Goldman Sachs Group Inc0.00%1,227,772$14,647,320$20,098,628+$5,451,308+37.22%
Bank Of America Corp0.00%1,216,955$14,518,273$19,921,553+$5,403,280+37.22%
Citadel Advisors Llc0.01%1,201,489$14,333,764$19,668,375+$5,334,611+37.22%
Nan Fung Trinity (Hk) Ltd1.50%1,142,950$13,635,394$18,710,092+$5,074,698+37.22%
Flputnam Investment Management Co0.19%1,063,301$12,685,181$17,406,237+$4,721,056+37.22%
Woodline Partners Lp0.05%1,000,782$11,939,329$16,382,801+$4,443,472+37.22%
Vanguard Portfolio Management Llc0.00%968,588$11,555,255$15,855,786+$4,300,531+37.22%
Charles Schwab Investment Management Inc0.00%840,572$10,028,024$13,760,164+$3,732,140+37.22%
Northern Trust Corp0.00%806,659$9,623,443$13,205,008+$3,581,565+37.22%
Candriam S.C.A.0.05%773,620$9,229,287$12,664,159+$3,434,872+37.22%
Morgan Stanley0.00%731,255$8,723,872$11,970,644+$3,246,772+37.22%
Vanguard Fiduciary Trust Co0.00%714,631$8,525,548$11,698,509+$3,172,961+37.22%
Panagora Asset Management Inc0.03%625,578$7,463,146$10,240,712+$2,777,566+37.22%
Sphera Funds Management Ltd.1.18%574,029$6,848,166$9,396,855+$2,548,689+37.22%
Millennium Management Llc0.01%570,971$6,811,684$9,346,795+$2,535,111+37.22%
Peregrine Capital Management Llc0.23%530,451$6,328,280$8,683,483+$2,355,203+37.22%
Burkehill Global Management, Lp0.31%525,000$6,263,250$8,594,250+$2,331,000+37.22%
Silverarc Capital Management, Llc0.72%511,127$6,097,745$8,367,149+$2,269,404+37.22%
Ameriprise Financial Inc0.00%504,836$6,022,693$8,264,165+$2,241,472+37.22%
Balyasny Asset Management L.P.0.01%473,849$5,653,019$7,756,908+$2,103,889+37.22%

Frequently asked questions about TRVI

  • Who owns the most TRVI stock?

    The largest holders of TRVI are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for TREVI THERAPEUTICS INC (TRVI).

  • Is TRVI widely held by superinvestors?

    Many widely followed stocks like TRVI appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly TRVI is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.